Skip to main content

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 195))

Abstract

Although attempts to enhance athletic performance are probably much older, the word “doping” was first mentioned in 1889 in an English dictionary. It described originally a mixed remedy containing opium, which was used to “dope” horses. “Dope” was a spirit prepared from the residues of grapes, which Zulu warriors used as a “stimulant” at fights and religious procedures and which also reportedly was called “doop” in Afrikaans or Dutch. Later, the meaning of “dope” was extended in a broader sense to other beverages with stimulating properties. The expression was introduced into English Turf Sport about 1900 for illegal drugging of racehorses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abourashed EA, El-Alfy AT, Khan IA et al (2003) Ephedra in perspective – a current review. Phytother Res 17:703–712

    Article  PubMed  CAS  Google Scholar 

  • Aguilera R, Becchi M, Casabianca H, Hatton C, Catlin DH, Starcevic B, Pope HG Jr (1996) Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids. J Mass Spectrom 31:169

    Article  PubMed  CAS  Google Scholar 

  • Ayotte C (2006) Significance of 19-norandrosterone in athletes’ urine samples. Br J Sports Med 40(Suppl 1):125

    Google Scholar 

  • Ayotte (2009) Detecting the administration of endogenous anabolic androgenic steroids. In: Thieme D, Hemmersbach P (eds) Doping in Sports, Handbook of Experimental Pharmacology 195, Springer, Heidelberg

    Google Scholar 

  • Badyshtov BA, Losev AS, Makhnycheva AL, Barchukov VG, Sytnik SI, Pastushenkov VA, Kolotilinskaia NV, Mironov SA, Morozov IS, Seredenin SB (1995) Study of heat-protective effects of bromantane at various levels of overheating. Vopr Med Khim 41:54

    PubMed  CAS  Google Scholar 

  • Becchi M, Aguilera R, Farizon Y, Flament MM, Casabianca H, James P (1994) Gas chromatography/combustion/isotope-ratio mass spectrometry analysis of urinary steroids to detect misuse of testosterone in sport. Rapid Commun Mass Spectrom 8:304

    Article  PubMed  CAS  Google Scholar 

  • Beckett AH (1992) Clenbuterol and sport. Lancet 340:1165

    Article  PubMed  Google Scholar 

  • Beckett AH, Cowan DA (1979) Misuse of drugs in sport. Br J Sports Med 2:185

    Google Scholar 

  • Beckett AH, Tucker GT, Moffat AC (1967) Routine detection and identification in urine of stimulants and other drugs, some of which may be used to modify performance in sport. J Pharm Pharmacol 19:273

    PubMed  CAS  Google Scholar 

  • Berendonk B (1992) Doping – von der Forschung zum Betrug. Rowohlt Hamburg, ISBN 3-499186-77-2

    Google Scholar 

  • Blickensdörfer H (1972) Der Tag, an dem Tom Simpson starb (The day when Tom Simpson died). In: Acker H (ed) Rekorde aus der Retorte (Records from the retort). Deutsche Verlagsanstalt, Stuttgart, p 104

    Google Scholar 

  • Breidbach A, Catlin DH (2001) RSR13, a potential athletic performance enhancement agent: Detection in urine by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 15:2379

    Article  PubMed  CAS  Google Scholar 

  • Brooks RV, Firth RG, Sumner NA (1975) Detection of anabolic steroids by radioimmunoassay. Br J Sports Med 9:89

    Article  PubMed  CAS  Google Scholar 

  • Brooks RV, Jeremiah G, Webb WA, Wheeler M (1979) Detection of anabolic steroid administration to athletes. J Steroid Biochemy 11:913

    Article  CAS  Google Scholar 

  • Bumat P, Payen A, Le Brumant-Payen C, Hugon M, Ceppa F (1997) Bromantan, a new doping agent. Lancet 350:963

    Google Scholar 

  • Burstin S (1963) La Lucha contra el Dopage. Revista de Derecho Sportiva, Buenos Aires 3/8–9:583

    Google Scholar 

  • Bux R, Zedler B, Schmidt P, Parzeller M (2008) Sudden unexpected death associated with sports. Frequency in autopsies between 1972 and 2007 (in German). Rechtsmedizin 18(3):155–160

    Article  Google Scholar 

  • Catlin DH (1987) Detection of drug use by athletes. In: Strauss RH (ed) Drugs and performance in sports. W.B. Saunders Co, Philadelphia, p 104

    Google Scholar 

  • Catlin DH (1999) Overview and drug monographs. In: International Olympic Committee Medical Commission Doping – An IOC White Paper, IOC Lausanne

    Google Scholar 

  • Catlin DH, Breidbach A, Elliott S, Glaspy J (2002) Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human erythropoietin, and endogenous erythropoietin from human urine. Clin Chem 48:2057

    PubMed  CAS  Google Scholar 

  • Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang YC, Hatton CK (2004) Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun Mass Spectrom 18:1245

    Article  PubMed  CAS  Google Scholar 

  • Chinery S (1983) Anabolic steroids and bodybuilding. SMS Publishing, Toms River, NJ, p 41

    Google Scholar 

  • Clasing D, Donike M, Klümper A (1974) Dopingkontrollen bei den Spielen der XX. Olympiade München 1972. Leistungssport 4:130 and 4:303

    Google Scholar 

  • Council of Europe (1989) Anti-doping convention (ETS No. 135) Council of Europe Strasbourg, ISBN 92-871-2765-4

    Google Scholar 

  • Deventer K, van Eenoo P, Delbeke FT (2006) Detection of hydroxyethylstarch (HES) in human urine by liquid chromatography–mass spectrometry. J Chrom B: Anal Technol Biomed Life Sci 834:217

    CAS  Google Scholar 

  • Dirix A (1984, 1992) Medical Guides International Olympic Committee Medical Commission, Lausanne

    Google Scholar 

  • Dirix A (1986) The doping problem at the Tokyo and Mexico City Olympic Games. J Sports Med Phys Fitness 6:183

    Google Scholar 

  • Dirix A, Sturbois X (1998) The first thirty years of the International Olympic Committee Medical Commission 1967–1997. International Olympic Committee (IOC Booklet Series “History and Facts”), Lausanne

    Google Scholar 

  • Donike M, Kaiser CH (1971) Moderne methoden der dopinganalyse. Sportarzt und Sportmedizin 3:57

    Google Scholar 

  • Donike M, Clasing D, Klümper A (1974) Dopingkontrollen bei den Spielen der XX. Olympiade München 1972 part 2. Leistungssport (Berlin) 4:192

    Google Scholar 

  • Donike M, Kaiser CM, Klehr HL (1976) Die Dopingkontrollen in Montreal. Bundesinstitut für Sportwissenschaft Köln, Selbstverlag

    Google Scholar 

  • Donike M, Bärwald KR, Klostermann K, Schänzer W, Zimmermann J (1983) Nachweis von exogenem Testosteron (Detection of endogenous testosterone). In: Heck H (ed) Sport: Leistung und Gesund- heit, Kongressband Deutscher Sportärztekongress 1982, Deutscher Ärzte Verlag Köln, p 293

    Google Scholar 

  • Donike M et al (1996) Blut und/oder Urin zur Dopingkontrolle. Bundesinstitut für Sportwissenschaft, vol 86, Verlag Karl Schorndorf Köln, ISBN 3-7780-8861-0

    Google Scholar 

  • Duchaine D (1989) Underground steroid handbook. HLR Technical Books, Venice, CA 90291

    Google Scholar 

  • Eckart WU (2003) Die grüne Muse. Süddeutsche Ztg. 96/ 26:14

    Google Scholar 

  • Edeleanu L (1887) Über einige Derivate der Phenylmethacrylsaure und der henylisobuttersaure. Ber Deutsch Chem Ges 20:616

    Article  Google Scholar 

  • Fahey T, Fritz B (1991) Steroid alternative handbook. Sports Science Publications, San José, CA, USA, p 29

    Google Scholar 

  • Fainaru M, Williams L (2003) Barry bonds: anatomy of a scandal. San Francisco Chronicle, http://www.seattlepi.com/baseball/153951_steriods25.html 05 April 2009

  • Fisher JW (2003) Erythropoietin: physiology and pharmacology update. Exp Biol Med 228:1–14

    CAS  Google Scholar 

  • Franke WW (1997) Hormonal doping and androgenizing of athletes: a secret program of the German Democratic Republic Government. Clin Chem 43/7:1262–1279

    Google Scholar 

  • Freeman ER, Bloom DA, McGuire EJ (2001) A brief history of testosterone. J Urol 165:371–373

    Article  PubMed  CAS  Google Scholar 

  • Goldmann B (1984) Death in the locker room. Icarus Press, South Bend

    Google Scholar 

  • Gore CJ, Parisotto R, Ashenden MJ, Stray-Gundersen J, Sharpe K, Hopkins W, Emslie KR, Howe C, Trout GJ, Kazlauskas R, Hahn AG (2003) Second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica 88:333

    PubMed  Google Scholar 

  • Grekhova TV, Gainetdinov RR, Sotnikova TD, Krasnykh LM, Kudrin VS, Sergeeva SA, Morozov IS (1995) The effect of bromantane, a new immunostimulant with psychostimulating action, on release and metabolism of dopamine in the dorsal striatum of freely moving rats: a microdialysis study. Biull Eksp Biol Med 119:302

    Article  PubMed  CAS  Google Scholar 

  • Hanley DF (1983) Drogen und Drogenmissbrauch (drugs and drug abuse). In: Strauss R (ed) Sportmedizin und Leistungsphysiologie, Enke Verlag Stuttgart, p 402

    Google Scholar 

  • Hemmersbach P (2008) History of mass spectrometry at the Olympic Games. J Mass Spectrom 43:839–853

    Article  PubMed  CAS  Google Scholar 

  • Hemmersbach P, de la Torre R (1996) Stimulants, narcotics and ß-blockers: 25 years of development in analytical techniques for doping control. J Chrom B 687:221

    Article  CAS  Google Scholar 

  • Horning S, Donike M (1994) High-resolution GC/MS. In: Donike M et al (eds) Recent advances in doping analysis – proceedings of the 11th cologne workshop, 7–12 March 1993. Sport und Buch Strauss, Köln, p 155

    Google Scholar 

  • Horning S, Geyer H, Machnik M, Schänzer W, Hilkert A, Oesselmann J (1996) Detection of exogenous testosterone by 13C/12C analysis. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis, vol 4. Sport und Buch Strauss, Köln, p 275

    Google Scholar 

  • Houlihan B (1999) Dying to win. Doping in sport and the development of anti-doping policy. Council of Europe, Strasbourg, ISBN 92-871-3589-4

    Google Scholar 

  • International Olympic Committee (IOC) Medical Commission (1972) Doping (published in cooperation with the International Organizing Committee for the Olympic Games in Munich and in Sapporo 1972), IOC Lausanne

    Google Scholar 

  • Jasuja R, Catlin DH, Miller A, Chang YC, Herbst KL, Starcevic B, Artaza JN, Singh R, Datta G, SarkissianA CC, Baker M, Bhasin S (2005) Tetrahydrogestrinone is an androgenic steroid that stimulates androgen receptor-mediated, myogenic differentiation in C3H10T1/2 multipotent mesenchymal cells and promotes musde accretion in orchidectomized male rats. Endocrinology 146:4472

    Article  PubMed  CAS  Google Scholar 

  • Kim S, Park JH, Myung SW, Lho DS (1999) Determination of carphedon in human urine by solid-phase microextraction using capillary gas chromatography with nitrogen–phosphorus detection. The Analyst 124:1559

    Article  PubMed  CAS  Google Scholar 

  • Kohler M, Thevis M, Schänzer W, Püschel K (2008) Damage to health and fatalities from doping (in German). Rechtsmedizin 18(3):177–182

    Article  Google Scholar 

  • Kudrin VS, Sergeeva SA, Krasnykh LM, Miroshnichenko II, Grekhova TV, Gainetdinov RR (1995) The effect of bromantane on the dopamin- and serotoninergic systems of the rat brain. Eksp Klin Farmakol 58:8

    PubMed  CAS  Google Scholar 

  • Lasne F (2001) Double-blotting: a solution to the problem of non-specific binding of secondary antibodies in immunoblotting procedures. J lmmunol Methods 53:125

    Article  Google Scholar 

  • Lasne F, de Ceaurriz J (2000) Recombinant erythropoietin in urine. Nature 405:635

    Article  PubMed  CAS  Google Scholar 

  • Lasne F, Martin L, Crepin N, de Ceaurriz J (2002) Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones. Anal Biochem 311:119

    Article  PubMed  CAS  Google Scholar 

  • Lüderwald S, Zinka B, Thieme D, Eisenmenger W (2008) Misuse of anabolic androgenic steroids. Fatal cases in recreational bodybuilding. Rechtsmedizin 18(3):183–188

    Article  Google Scholar 

  • Maltin CA, Delday MI, Hay SM, Smith FG, Lobley GE, Reeds PJ (1987a) The effect of the anabolic agent clenbuterol on overloaded rat skeletal muscle. Biosci Rep 7:143

    Article  PubMed  CAS  Google Scholar 

  • Maltin CA, Hay SM, Delday MI, Smith FG, Lobley GE, Reeds PJ (1987b) Clenbuterol, a beta agonist, induces growth in innervated and denervated rat soleus muscle via apparently different mechanisms. Biosci Rep 7:525

    Article  PubMed  CAS  Google Scholar 

  • Mareck U, Geyer H, Opfermann G, Thevis M, Schänzer W (2008) Factors influencing the steroid profile in doping controlanalysis. J Mass Spectrom. 43:7. doi:10.1002/jms.1457

    Article  CAS  Google Scholar 

  • Maurer HH (2006) Hyphenated mass spectrometric techniques–indispensable tools in clinical and forensic toxicology and in doping control. J Mass Spectrom 41:1399

    Article  PubMed  CAS  Google Scholar 

  • McLaren R (2001) International Sports law perspective: introducing the court for arbitration for sport – the ad-hoc division at the Olympic Games. Marquette Sports Law Rev 12:515

    Google Scholar 

  • Merode, Prince A de (1999) Introduction and background in: International Olympic Committee Medical Commission Doping – An IOC White Paper, IOC Lausanne

    Google Scholar 

  • Michna H (ed) Biomedical side effects of doping. Scientific Reports of the Federal Institute of Sport Sciences Bonn, vol 23, Sport und Buch Strauss Köln, ISBN 3-89001-363-5

    Google Scholar 

  • Müller RK (2000) Doping relevance and doping definition – suggested extension of the IOC list of examples to the banned groups of substances. In: Biology of Sport, vol 17/2, pp 73–80

    Google Scholar 

  • Müller RK (2001) Am horizont: gendoping im sport? In: Güldenpfennig S, Krickow D (eds) Jahrbuch des Deutschen Olympischen Instituts, Berlin, ISBN 3-9807747-1-6, pp 249–260

    Google Scholar 

  • Müller RK, Müller-Platz (2001) Aggression and anabolic steroid hormones. Do anabolic androgenic steroids enhance aggressiveness? In: Michna H (ed) Biomedical side effects of doping. Scientific Reports of the Federal Institute of Sport Sciences Bonn, vol 23. Sport und Buch Strauss, Köln, ISBN 3-89001-363-5, pp 107–113

    Google Scholar 

  • Müller RK, Thieme D (eds) (2000) Progress in hair analysis for illegal drugs. Scientific reports and materials of the Federal Institute of Sport Sciences, Bonn. Sport und Buch Strauss, Köln, ISBN 3-89001-335-X

    Google Scholar 

  • Müller RK, Grosse J, Thieme D, Lang R (1999) Carphedon – Identifikation einer neuen Designerdroge. Rechtsmedizin 9:215

    Article  Google Scholar 

  • Müller RK, Grosse J, Thieme D, Preiss R (2000) Banned agents and related compounds – how many? In: SchänzerW, Geyer H, Gotzmann A, Marek-Engelke U (eds) Recent advances in doping analysis 7. Sport und Buch Strauss, Köln, ISBN-3-89001-335-X

    Google Scholar 

  • Müller RK, Grosse J, Wahl A (2003) Doping. In: Madea B, Brinkmann B (eds) Handbuch der gerichtlichen Medizin (Manual of Forensic Medicine). Springer, Berlin, pp 188–198

    Google Scholar 

  • Parisotto R, Gore CJ, Emslie KR, Ashenden MJ, Brugnara C, Howe C, Martin DT, Trout GJ, Hahn AG (2000) A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologica 85:564

    PubMed  CAS  Google Scholar 

  • Parisotto R, Wu M, Ashenden MJ, Emslie KR, Gore CJ, Howe C, Kazlauskas R, Sharpe K, Trout GJ, Xie M (2001) Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica 86:128

    PubMed  CAS  Google Scholar 

  • Peters C, Schulz T, Michna H (2001) Biomedical side effects of doping. Bundesinstitut für Sportwissenschaft Köln, Sport und Buch Strauss, ISBN 3-89001-363-5

    Google Scholar 

  • Pfleger K, Maurer HH, Weber A (2000) Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites, Part 4. Wiley-VCH Weinheim

    Google Scholar 

  • Pini M-C (1964) Estudo critico da dopago, Sao Paulo

    Google Scholar 

  • Pozo OJ, Deventer K, Van Eenoo P, Delbeke F (2008) Efficient approach for the comprehensive detection of unknown anabolic steroids and metabolites in human urine by liquid chromatography–electrospray-tandem mass spectrometry. Analyt Chem 80:1709

    Article  CAS  Google Scholar 

  • Prokop L (1957) Leistungssteigerung durch Placebos (Performance enhancement by placebos), XI. Congres International de Medicine Sportive, Luxembourg

    Google Scholar 

  • Prokop L (1970) The struggle against doping and its history. J Sports Med Phys Fitness 10:45

    PubMed  CAS  Google Scholar 

  • Prokop L (1972) Zur Geschichte des Dopings (On the history of doping). In: Acker H (ed) Rekorde aus der Retorte (records from the retort), Deutsche Verlagsanstalt Stuttgart, p 22

    Google Scholar 

  • Prokop L (2002) Lecture on the history of doping. Antidoping Laboratory, Austrian Research Center Seibersdorf

    Google Scholar 

  • Raschka C (2008) Fatal doping cases in sport. A historical review (in German). Rechtsmedizin 18(3):173–176

    Article  Google Scholar 

  • Sachs H, Kintz P (2000) Consensus if the Society of Hair Testing on hair testing for doping agents. Forensic Sci Int 107:3

    Article  Google Scholar 

  • Sachs H, Möller RM (1989) Detection of drugs in hair by GC/MS. Fresenius Z Anal Chem 334:713

    Google Scholar 

  • Shackleton CHL, Phillips A, Chang T, Li Y (1997) Confirming testosterone administration by isotope ratio mass spectrometric analysis of urinary androstanediols. Steroids 62:379

    Article  PubMed  CAS  Google Scholar 

  • Spitzer G (1989) Doping in der DDR. Bundesinstitut für Sportwissenschaft, Köln, Sport und Buch Strauss Bonn, ISBN 3-89001-315-5

    Google Scholar 

  • Spitzer G (2005a) Sicherungsvorgang Sport – Das Ministerium für Staatssicherheit und der DDR-Spitzensport. Bundesinstitut für Sportwissenschaft Bonn, Verlag Hofmann, Schorndorf, ISBN 3-7780-8971-4

    Google Scholar 

  • Spitzer G (2005b) Schon Hitler nahm Testosteron. http://www.faz.net/s/Rub906784803A9943C4A3399622FC846D0D/Doc~E15C38CBE153048898F5CB707B0DC80D1~ATpl~Ecommon~Scontent.html Cited 10 April 2009

  • Spitzer G, Teichler HJ, Reinartz K (1999) Das Leistungssportsystem der DDR in den 80er Jahren und im Prozess der Wende. Bundesinstitut für Sportwissenschaft Bonn, Verlag Hofmann, Schorndorf, ISBN 3-7780-8961-7

    Google Scholar 

  • Teichler HJ (2003) Sport in der DDR – Eigensinn, Konflikte, Trends. Bundesinstitut für Sportwissenschaft Bonn, Sport und Buch Strauss Köln, ISBN 3-89001-387-2

    Google Scholar 

  • Thevis M, Schänzer W (2005) Mass spectrometry in doping control analysis. Curr Org Chem 9:825

    Article  CAS  Google Scholar 

  • Thevis M, Schänzer W (2007) Mass spectrometry in sports drug testing: structure characterization and analytical assays. Mass Spectrom Rev 26:79

    Article  PubMed  CAS  Google Scholar 

  • Thevis M, Opfermann G, Schänzer W (2000) Detection of the plasma volume expander hydroxyethyl starch in human urine. J Chromatogr B 744:345

    Article  CAS  Google Scholar 

  • Thevis M, Geyer H, Mareck U, Schänzer W (2005) Screening for unknown synthetic steroids in human urine by liquid chromatography–tandem mass spectrometry. J Mass Spectrom. 40:955

    Article  PubMed  CAS  Google Scholar 

  • Todd J, Todd T (2001) Significant events in the history of drug testing and the Olympic movement: 1960–1999. In: Wilson W, Derse E (eds) Doping in elite sport – The politics of drugs in the Olympic Movement. Human Kinetics Publishers

    Google Scholar 

  • US Food and Drug Administration. Dietary Supplement and health education act. http://www.fda.gov/opacom/laws/ dshea.html, Cited 05 April 2008

  • UNESCO (2005) International Convention against Doping in Sport 2005, http://portal.unesco.org/en/ev.php-URL_ID=31037&URL_DO&DO_TOPIC&URL_SECTION=201.html. Cited 24 September 2009

  • Venerando A (1963) Pathologia del Doping e mezzi di controllo. Medicine dello Sport, Roma, p 3

    Google Scholar 

  • WADA (World Anti-Doping Agency) (2008a) The 2009 Prohibited List. http://www.wada-ama.org/rtecontent/document/2009_Prohibited_List_ENG_Final_20_Sept_08.pdf. Cited 10 April 2009

  • WADA (World Anti-Doping Agency) (2008b) International Standard for laboratories, Version 5.0, http://www.wada-ama.org/rtecontent/ document/lab-08_V_05.pdf

  • WADA (World Anti-Doping Agency) (2008c) WADA-accredited laboratories. http://www.wada-ama.org/en/dynamic.ch2?pageCategory.id=333, Cited 09 April 2009

  • WADA (World Anti-Doping Agency) (2008d) Independent observer report. http://www.wada-ama.org/rtecontent/document/sydney_ io_report.pdf

  • WADA (World Anti-Doping Agency) (2009a) A brief history of anti-doping. http://www.wada-ama.org/en/dynamic.ch2?pageCategory.id=312, Cited 10 April 2009

  • WADA (World Anti-Doping Agency) (2009b) World Anti-Doping Code, http://www.wada-ama.org/rtecontent/document/code_v2009_En.pdf. Cited 24 September 2009

  • Wadler GI, Hainline B (1989) Drugs and the athlete. FA Davis Company, Philadelphia, ISBN 0-8036-9008-8

    Google Scholar 

  • Westwood S, Noble B, Moule C (1999) Synthesis and characterisation of steroid metabolites for use as analytical reference materials. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis – proceedings of the 17th cologne workshop, 14–19 March 1999, vol 7. Sport und Buch Strauss Köln, p 181

    Google Scholar 

  • Wright JE, Cowart VS (1990) Anabolic steroids: altered states. Cooper Publishing Group, Traverse City, USA

    Google Scholar 

  • Yates D, Wolff B (1993) Blood and guts – The ultimate approach to building maximum muscle mass (German translation 1995: Blut und Schweiss, Sport Verlag Ingenohl, Heilbronn)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rudhard Klaus Müller .

Editor information

Editors and Affiliations

1 Appendix 1 Historical Definitions of Doping

1933 Beckmanns Sport Lexikon

Doping, the use of stimulating (performance enhancing) agents, which shall push the atlete beyond his/her normal limits of performance.

Used for this purpose are:

Adrenalin, extracts of testes, caffeine, digitalis, strychnine, camphor, nicotine, cocaine, colanine, heroin, morphine, arsenic, phosphorous, calcium, alcohol etc.

The application of doping agents is rejected for reasons of sports ethics and health and is sanctioned in many sport disciplines by dismissal and sanctions.

1952 Association of German Sport Physicians (Deutscher Sportärztebund)

The intake of any pharmaceutical – regardless its activity – with the intention to enhance performance during a competition is considered as doping.

1952 Keysers Sportlexikon

Doping: Administration of stimulating agents for the enhancement of performance in sport. Application before or during the competition causes disqualification.

1956 Lexikon des Sportes (Dictionary of Sport)

Doping: Attempts by artificial stimulants of any kind, to enhance the performance of the body beyond the natural limits.

1963 Council of Europe (Madrid)

If a necessary medical treatment carried out by any means, which by its nature is capable to enhance physical performance beyond the normal level, this is considered as doping and excludes the capability to compete.

1963 Council of Europe, Committee of General (Out-of-school) Education

Doping is the administration or the use of xenobiotic substances in each form and on each way or of physiological substances in abnormal form or by abnormal ways to healthy persons with the only aim of artificial and unfair enhancement of performance for competition. In addition, various psychological measures for performance enhancement of the athlete have to be considered as doping.

1965 Belgian Law

It is the intention of this Law that doping is considered as the use of substances or the application of methods for the artificial enhancement of performance of an athlete, who participates in a competition or prepares for a competition, if the use can be harmful for his physical or mental integrity.

The Anti-Doping Committee recommends that the Legislative should prepare such a list of substances and methods, including an adequate declaration of the prohibited doses of these substances.

1970 German Sports League (Deutscher Sportbund)

Doping is the attempt to obtain an increase of performance of athletes for competition by nonphysiological substances. Doping substances as defined by these Guidelines are phenylethylamine derivatives (strong central stimulants or “Weckamines”, ephedrines, adrenaline derivatives), narcotics, analeptics (camphor- and strychnine derivatives), sedatives, psychopharmaceuticals and alcohol.

1971 Medical Commission of the International Olympic Committee:

All substances, also if applied for therapeutic purposes, which influence performance by their composition or dosage, are doping agents, including in particular

  1. 1.

    Sympathomimetic amines (e.g. amphetamines, ephedrines, etc.)

  2. 2.

    Central stimulants (e.g. strychnine, analeptics, etc.)

  3. 3.

    Narcotic analgesics (e.g. morphine, methadone, etc.)

1971 German Track and Field Association (Deutscher Leichtathletik-Verband, DLV)

“Each athlete is prohibited to take part in a competition, if he/she is under the influence of pharmaceuticals on the prohibited list. The proof of doping is obtained by qualitative detection. Time, dosage and potential of the agent are irrelevant.”

1976 International Olympic Committee

A definition of doping is not introduced.

Doping comprises the application of the substances on the following list. This list contains 76 different agents.

  1. 1.

    Psychomotoric stimulants: amphetamines and derivatives. Sympathomimetic amines: ephedrine and derivatives. Central nervous stimulating substances: analeptics, strychnine

  2. 2.

    Narcotics and analgesics: morphine and derivatives

  3. 3.

    Vasodilatators: nitrites

  4. 4.

    Anabolic steroides

1977 German Association of Sport Physicians (Deutscher Sportärztebund)

  1. 1.

    Doping is the attempt at unphysiological enhancement of performance of an athlete by application (intake, injection or administration) of a doping substance by the athlete or an assisting person (e.g. team leader, coach, physician, nurse or physiotherapist) prior to a competition and, for the anabolic hormones, also during training.

  2. 2.

    Doping substances according to these guidelines are in particular: Phenylethylamine derivatives (“Weckamines”), ephedrines, adrenaline derivatives, narcotics, analeptics (camphor and strychnine derivatives) and anabolic hormones. In specific sports, additional substances can be prohibited as doping agents (e.g. alcohol, sedatives, psychopharmaceuticals).

1978 German Association of Sport Physicians

Doping is the use of substances from the prohibited classes of agents:

  1. (a)

    Psychomotoric stimulants

  2. (b)

    Sympathomimetic amines

  3. (c)

    Various stimulants of the Central Nervous System

  4. (d)

    Narcotis and analgesics

  5. (e)

    Anabolic steroids

1986 German Association of Sport Physicians

Doping is the use of substances belonging to the prohibited classes of agents, and the application of non-permitted measures like blood doping.

Five classes of substances are defined as doping agents:

  1. 1.

    Psychomotoric substances (stimulants)

  2. 2.

    Narcotics

  3. 3.

    Anabolic steroids

  4. 4.

    Beta-receptor blockers

  5. 5.

    Diuretics

1988 International Olympic Committee

Doping is the use of substances from the prohibited classes of agents and the use of prohibited methods.

List of prohibited classes of substances and methods

  1. I.

    Prohibited classes of substances

    1. A.

      Stimulants

    2. B.

      Narcotics

    3. C.

      Anabolic steroids

    4. D.

      Beta-receptor blockers

    5. E.

      Diuretics

  2. II.

    Prohibited methods

    1. A.

      Blood doping

    2. B.

      Pharmacological, chemical and physical manipulation

  3. III.

    Substances, permitted with certain restrictions

    1. A.

      Alcohol

    2. B.

      Local aneasthetics

    3. C.

      Corticosteroids

1989 Anti-Doping Convention of the Council of Europe

According to this Convention are defined

“Doping in sport” the administration to or the use of pharmacological doping agents or of doping methods by athletes.

  1. (a)

    Pharmacological doping agents or doping methods according to paragraph 2 are those doping agents or doping methods which have been prohibited by the respective international sport organisations and are included in lists, which according to article II.1b. are confirmed by the Monitoring Group,

  2. (b)

    “Athletes” are those persons who participate regularly in organised sporting activities.

Until the date when a list with the prohibited doping agents and methods has been confirmed by the Monitoring Group according to Article II.I.b., the list of agents and methods attached to this Convention is valid as List of Agents and Methods.

Doping in this sense means each attempt to enhance performance by means, which normally are not administrated to the organism, whereby the intention of stimulation is essential and the manner of administration is irrelevant.

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Müller, R.K. (2010). History of Doping and Doping Control. In: Thieme, D., Hemmersbach, P. (eds) Doping in Sports: Biochemical Principles, Effects and Analysis. Handbook of Experimental Pharmacology, vol 195. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79088-4_1

Download citation

Publish with us

Policies and ethics